Form 8-K

8-K — Westlake Chemical Partners LP

Accession: 0001604665-26-000022

Filed: 2026-08-04

Period: 2026-08-04

CIK: 0001604665

SIC: 2860 (INDUSTRIAL ORGANIC CHEMICALS)

Item: Results of Operations and Financial Condition

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — wlkp-20260804.htm (Primary)

EX-99.1 (ex991_20260630earningsrele.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: wlkp-20260804.htm · Sequence: 1

wlkp-20260804

0001604665false00016046652026-08-042026-08-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 4, 2026

Westlake Chemical Partners LP

(Exact name of registrant as specified in its charter)

Delaware 001-36567 32-0436529

(State or other jurisdiction

of incorporation) (Commission File Number) (I.R.S. Employer

Identification No.)

2801 Post Oak Boulevard, Suite 600 77056

Houston, Texas

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (713) 585-2900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common units representing limited partnership interests WLKP The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Item 2.02. Results of Operations and Financial Condition.

On August 4, 2026, Westlake Chemical Partners LP (the "Partnership") issued a press release announcing its 2026 second quarter results. A copy of the press release is furnished with this Current Report as Exhibit 99.1.

The information furnished pursuant to this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing by Westlake Chemical Partners LP under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, unless specifically identified as being incorporated therein.

Item 7.01. Regulation FD Disclosure.

The Partnership is holding a conference call on August 4, 2026 to discuss its 2026 second quarter results. Information about the call can be found in the press release furnished with this Current Report as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are furnished herewith:

99.1 Press release issued on August 4, 2026.

104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WESTLAKE CHEMICAL PARTNERS LP

By: Westlake Chemical Partners GP LLC

Date: August 4, 2026 By:

/S/ JEAN-MARC GILSON

Jean-Marc Gilson

President, Chief Executive Officer and Director

EX-99.1

Filename: ex991_20260630earningsrele.htm · Sequence: 2

Document

EXHIBIT 99.1

WESTLAKE CHEMICAL PARTNERS LP

Contact—(713) 585-2900

Investors—Jonathan Baksht

Media—L. Benjamin Ederington

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

•Declared quarterly distribution of $0.4714 per unit; 48th consecutive quarterly distribution

HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was slightly below second quarter 2025 net income of $14.6 million. Cash flows from operating activities in the second quarter of 2026 were $129.8 million, an increase of $120.7 million compared to second quarter 2025 cash flows from operating activities of $9.1 million, primarily due to higher production and sales volume and lower maintenance capital expenditures as the result of the prior year's Petro 1 turnaround. For the three months ended June 30, 2026, MLP distributable cash flow was $17.6 million, an increase of $2.6 million compared to second quarter 2025 MLP distributable cash flow of $15.0 million. The increase in MLP distributable cash flow and associated trailing twelve-month coverage ratio of 1.04x was primarily due to higher production and sales volume and lower maintenance capital expenditures as a result of the prior year's Petro 1 turnaround.

Compared to the first quarter, second quarter 2026 net income attributable to the Partnership was unchanged at $14.2 million. Second quarter 2026 cash flows from operating activities of $129.8 million increased by $19.6 million due to working capital changes. Second quarter 2026 MLP distributable cash flow of $17.6 million decreased by $0.3 million compared to first quarter 2026 MLP distributable cash flow of $17.9 million due to higher maintenance capital expenditures.

"We were pleased with the Partnership's performance in the second quarter as we benefited from higher third-party ethylene prices and the continued stability of our cash flows due to the ethylene sales agreement with Westlake," said Jean-Marc Gilson, President and Chief Executive Officer. "Looking forward, we expect to continue to provide strong returns and predictable cash flows to our unitholders."

On July 8, 2026, both the Partnership and Westlake Chemical OpCo LP ("OpCo") entered into amendments to their respective senior unsecured revolving credit agreements with Westlake Corporation. These amendments extended the maturity dates of the facilities to July 2031.

On August 3, 2026, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the second quarter of 2026 of $0.4714 per common unit to be payable on August 28, 2026 to unitholders of record as of August 13, 2026, representing the 48th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage that was 1.04x the declared distributions for the second quarter of 2026, which was above the trailing twelve-month coverage ratio of 1.00x at the end of the first quarter. Since our IPO in July of 2014 our cumulative coverage ratio is approximately 1.05x.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to: our financing arrangements with Westlake; the timing and results of our turnaround activities, our outlook for third-party ethylene margins, the impact of the conflict in the Middle East on global demand for our products, our expectations regarding feedstock and energy costs, our ability to deliver value, returns, predictable cash flows and distributions to unitholders; our relationship with Westlake and the benefits of the ethylene sales agreement, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to: operating difficulties or disruptions; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake, including determinations made pursuant to contractual arrangements with Westlake; the effects of legal proceedings; actions of third parties; inclement or hazardous weather conditions; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; inability of our customers to take delivery; fires, explosions or other industrial accidents; political tension and conflict in the Middle East and elsewhere; the supply/demand balance for our products; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC in March 2026, and the Partnership’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, which was filed with the SEC in May 2026.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' second quarter 2026 results will be held Tuesday, August 4, 2026 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register-conf.media-server.com/register/BI51826be52fb84f029203dae034f42aa3. A dial-in will be provided upon registration.

The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/ssbetq3b and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.

iii

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended June 30, Six Months Ended June 30,

2026 2025 2026 2025

(In thousands of dollars, except per unit data)

Revenue

Net sales—Westlake Corporation ("Westlake") $ 238,030 $ 269,076 $ 501,121 $ 459,857

Net co-products, ethylene and other sales—third parties 59,070 28,043 101,654 74,891

Total net sales 297,100 297,119 602,775 534,748

Cost of sales 202,295 199,587 414,211 383,135

Gross profit 94,805 97,532 188,564 151,613

Selling, general and administrative expenses 7,494 6,300 14,684 13,774

Income from operations 87,311 91,232 173,880 137,839

Other income (expense)

Interest expense—Westlake (5,119) (5,907) (10,204) (11,444)

Other income, net 348 675 696 2,021

Income before income taxes 82,540 86,000 164,372 128,416

Provision for income taxes 178 205 355 312

Net income 82,362 85,795 164,017 128,104

Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo") 68,124 71,237 135,610 108,598

Net income attributable to Westlake Partners $ 14,238 $ 14,558 $ 28,407 $ 19,506

Net income per limited partner unit attributable to Westlake Partners (basic and diluted)

Common units $ 0.40 $ 0.41 $ 0.81 $ 0.55

Distributions declared per unit $ 0.4714 $ 0.4714 $ 0.9428 $ 0.9428

MLP distributable cash flow $ 17,636 $ 15,007 $ 35,522 $ 19,721

Distributions declared

Limited partner units—publicly and privately held $ 9,958 $ 9,955 $ 19,916 $ 19,909

Limited partner units—Westlake 6,657 6,657 13,314 13,314

Total distributions declared $ 16,615 $ 16,612 $ 33,230 $ 33,223

EBITDA $ 122,687 $ 124,391 $ 243,903 $ 199,412

WESTLAKE CHEMICAL PARTNERS LP

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

June 30,

2026 December 31,

2025

(In thousands of dollars)

ASSETS

Current assets

Cash and cash equivalents $ 49,321 $ 44,269

Receivable under the Investment Management Agreement—Westlake 43,577 23,378

Accounts receivable, net—Westlake 39,464 63,571

Accounts receivable, net—third parties 21,602 9,113

Inventories 3,563 2,769

Prepaid expenses and other current assets 10 406

Total current assets 157,537 143,506

Property, plant and equipment, net 858,643 886,012

Other assets, net 201,168 227,015

Total assets $ 1,217,348 $ 1,256,533

LIABILITIES AND EQUITY

Current liabilities (accounts payable and accrued and other liabilities) $ 45,768 $ 51,301

Long-term debt payable to Westlake 399,674 399,674

Other liabilities 2,493 3,206

Total liabilities 447,935 454,181

Common unitholders—publicly and privately held 457,957 460,848

Common unitholder—Westlake 38,328 40,260

General partner—Westlake (242,572) (242,572)

Total Westlake Partners partners' capital 253,713 258,536

Noncontrolling interest in OpCo 515,700 543,816

Total equity 769,413 802,352

Total liabilities and equity $ 1,217,348 $ 1,256,533

WESTLAKE CHEMICAL PARTNERS LP

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Six Months Ended June 30,

2026 2025

(In thousands of dollars)

Cash flows from operating activities

Net income $ 164,017 $ 128,104

Adjustments to reconcile net income to net cash provided by operating activities

Depreciation and amortization 69,327 59,552

Net loss on disposition and other 2,356 524

Other balance sheet changes 4,345 (133,328)

Net cash provided by operating activities 240,045 54,852

Cash flows from investing activities

Additions to property, plant and equipment (18,037) (40,336)

Investments with Westlake under the Investment Management Agreement (20,000) —

Maturities of investments with Westlake under the Investment Management Agreement — 90,000

Net cash provided by (used for) investing activities

(38,037) 49,664

Cash flows from financing activities

Proceeds from debt payable to Westlake 82,000 95,000

Repayment of debt payable to Westlake (82,000) (95,000)

Distributions to noncontrolling interest retained in OpCo by Westlake (163,726) (93,031)

Distributions to unitholders (33,230) (33,222)

Net cash used for financing activities (196,956) (126,253)

Net increase (decrease) in cash and cash equivalents

5,052 (21,737)

Cash and cash equivalents at beginning of period 44,269 58,316

Cash and cash equivalents at end of period $ 49,321 $ 36,579

WESTLAKE CHEMICAL PARTNERS LP

RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

AND NET CASH PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

Three Months Ended March 31, Three Months Ended June 30, Six Months Ended June 30,

2026 2026 2025 2026 2025

(In thousands of dollars)

Net cash provided by operating activities $ 110,198 $ 129,847 $ 9,071 $ 240,045 $ 54,852

Changes in operating assets and liabilities and other (28,543) (47,485) 76,724 (76,028) 73,252

Net income 81,655 82,362 85,795 164,017 128,104

Add:

Depreciation, amortization and disposition of property, plant and equipment 34,360 37,155 32,872 71,515 60,043

Less:

Contribution to turnaround reserves (10,232) (10,305) (10,396) (20,537) (18,018)

Maintenance capital expenditures (7,810) (11,932) (20,506) (19,742) (41,083)

Distributable cash flow attributable to noncontrolling interest in OpCo (80,087) (79,644) (72,758) (159,731) (109,325)

MLP distributable cash flow $ 17,886 $ 17,636 $ 15,007 $ 35,522 $ 19,721

vii

WESTLAKE CHEMICAL PARTNERS LP

RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH

PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

Three Months Ended March 31, Three Months Ended June 30, Six Months Ended June 30,

2026 2026 2025 2026 2025

(In thousands of dollars)

Net cash provided by operating activities $ 110,198 $ 129,847 $ 9,071 $ 240,045 $ 54,852

Changes in operating assets and liabilities and other (28,543) (47,485) 76,724 (76,028) 73,252

Net income 81,655 82,362 85,795 164,017 128,104

Less:

Other income, net 348 348 675 696 2,021

Interest expense—Westlake (5,085) (5,119) (5,907) (10,204) (11,444)

Provision for income taxes (177) (178) (205) (355) (312)

Income from operations 86,569 87,311 91,232 173,880 137,839

Add:

Depreciation and amortization 34,299 35,028 32,484 69,327 59,552

Other income, net 348 348 675 696 2,021

EBITDA $ 121,216 $ 122,687 $ 124,391 $ 243,903 $ 199,412

viii

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover Page

Aug. 04, 2026

Cover [Abstract]

Document Type

8-K

Document Period End Date

Aug. 04, 2026

Entity Registrant Name

Westlake Chemical Partners LP

Entity Incorporation, State or Country Code

Entity File Number

001-36567

Entity Tax Identification Number

32-0436529

Entity Address, Address Line One

2801 Post Oak Boulevard,

Entity Address, Address Line Two

Suite 600

Entity Address, City or Town

Houston,

Entity Address, State or Province

Entity Address, Postal Zip Code

77056

City Area Code

713

Local Phone Number

585-2900

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common units representing limited partnership interests

Trading Symbol

WLKP

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

Entity Central Index Key

0001604665

Amendment Flag

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration